Brookline Capital Acquisition Corp WT (BCACW)
Brookline Capital Acquisition Corp WT (BCACW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCACW | SBFM | CUVL | ||
| Company | Brookline Capital Acquisition Corp WT | Sunshine Biopharma | Clinuvel Pharmaceuticals Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.2450 | 1.2100 | 6.90 | ||
| High | 0.6799 | 1.2100 | 6.90 | ||
| Low | 0.2450 | 1.1700 | 6.60 | ||
| Last | 0.5500 | 1.1894 | 6.68 | ||
| Change | +0.3100 | -0.0206 | -0.18 | ||
| Percent Change | +129.17% | -1.70% | -2.62% | ||
| Volume | 901,100 | 56,305 | 2,300 | ||
| 20-Day Average Volume | 59,175 | 839,155 | 6,315 | ||
| Previous | 0.2400 | 1.2100 | 6.86 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1819 | 1.4175 | 6.92 | ||
| 20-Day Raw Stochastic | 77.37% | 12.82% | 24.12% | ||
| 20-Day Relative Strength | 84.53 | 29.73 | 46.56 | ||
| Weighted Alpha | -69.67 | -79.30 | -20.61 | ||
| Today's Opinion | 8% Buy | 100% Sell | 88% Sell | ||
| Yesterday's Opinion | 24% Sell | 100% Sell | 80% Sell | ||
| Last Month's Opinion | 96% Sell | 100% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +185.42% since 07/22/22 | -14.29% since 08/06/26 | +2.70% since 08/05/26 | ||
| Low | 0.1500 on 07/25/22 | 1.1200 on 08/07/26 | 6.43 on 08/07/26 | ||
| High | 0.6799 on 07/29/22 | 1.5000 on 08/07/26 | 7.04 on 08/07/26 | ||
| 1-Month | |||||
| %Chg | +358.33% since 06/28/22 | -38.46% since 07/13/26 | -7.73% since 07/10/26 | ||
| Low | 0.1002 on 06/30/22 | 1.1000 on 07/30/26 | 6.20 on 08/03/26 | ||
| High | 0.6799 on 07/29/22 | 1.9600 on 07/14/26 | 8.19 on 07/20/26 | ||
| 3-Month | |||||
| %Chg | +292.86% since 04/29/22 | -81.82% since 05/13/26 | unch since 05/11/26 | ||
| Low | 0.0600 on 05/12/22 | 1.1000 on 07/30/26 | 5.98 on 05/19/26 | ||
| High | 0.6799 on 07/29/22 | 23.2000 on 05/18/26 | 8.19 on 07/20/26 | ||
| 6-Month | |||||
| %Chg | +52.78% since 01/28/22 | -89.74% since 02/13/26 | -12.11% since 02/12/26 | ||
| Low | 0.0600 on 05/12/22 | 1.1000 on 07/30/26 | 5.98 on 05/19/26 | ||
| High | 0.6799 on 07/29/22 | 23.2000 on 05/18/26 | 8.52 on 02/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 606 | 0 | ||
| Shares Outstanding, K | N/A | 501 | 0 | ||
| Annual Sales, $M | 0 | 36,310,000 | 95,017,570 | ||
| Annual Net Income, $M | -480,000 | -5,980,000 | 36,172,518 | ||
| Last Qtr Sales, $M | 0 | 8,090,000 | N/A | ||
| Last Qtr Income, $M | -2,457,658 | -1,240,000 | N/A | ||
| 60-Month Beta | N/A | 1.16 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -2.50 on 05/13/26 | N/A | ||
| Latest Earnings Date | 01/01/70 | 08/11/26 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||